Patent · US Active

Potency test for vaccine formulations

US8546149B2 · kind B2 · utility

4Cited by

2References

9Claims

0Family size

Assignees

Intervet Inc. · US
INTERVET INTERNATIONAL B.V · NL

Inventors

Michelle Allen · De Soto, US
Mark Garrett · Overland Park, US
Urs Peter Bruderer · Kleve, DE
Martinus Antonius Johannes Thijssen · Groeningen, NL

Key dates

Filing date	Sep 3, 2010
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Jun 18, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/04
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to certain methods for the determination of an antigen content of a first antigen in a mixture comprising two or more antigens. The invention also relates to a potency test for an antigen in a combination vaccine. The method allows the determination of the antigen content in a mixture additionally comprising antibodies that are capable of binding with the antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.